Recombivax Hb 40 mcg (Hepatitis B Surface Antigen (Recombinant) SUSPENSION) 40 MCG

RECOMBIVAX HB 40 MCG is a hepatitis B vaccine designed to prevent infection. This recombinant suspension is administered intramuscularly for broad immunity support.

Strength

40 MCG

Pack Size

1ML

Manufacturer / TM Owner

MERCK CANADA INC

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

RECOMBIVAX HB 40 MCG is used to stimulate the production of antibodies against hepatitis B virus. It is commonly administered to individuals at risk of exposure or those requiring long-term protection. This vaccine is part of a preventive healthcare strategy to reduce the risk of hepatitis B infection.

Side Effects

Common effects of RECOMBIVAX HB 40 MCG may include mild soreness or redness at the injection site. Some individuals might experience temporary fatigue or low-grade fever following vaccination. These effects are generally short-lived and resolve on their own.

Precautions & Warnings

RECOMBIVAX HB 40 MCG should be stored as directed to maintain its efficacy. It is important to inform healthcare providers of any allergies or medical conditions before administration. Follow the recommended schedule for optimal protection.

Avoid Interactions

RECOMBIVAX HB 40 MCG may interact with certain medications or other vaccines. It is advisable to discuss current medications with a healthcare provider before receiving this vaccine. Avoid alcohol or other immune-suppressing substances around the time of vaccination.

Frequently Asked Questions

RECOMBIVAX HB 40 MCG is used to prevent hepatitis B infection by stimulating the immune system to produce protective antibodies.

RECOMBIVAX HB 40 MCG is administered as an intramuscular injection, typically in the upper arm or thigh.

Common side effects may include soreness at the injection site, mild fever, or temporary fatigue.

It is important to consult a healthcare provider about any current medications before receiving RECOMBIVAX HB 40 MCG.

Individuals with severe allergies to vaccine components or those with certain medical conditions should consult a healthcare provider before receiving RECOMBIVAX HB 40 MCG.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated: 29 Jul 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.